C07C 50/20
With unsaturation outside the ring system
Official title: with unsaturation outside the ring system
C07C50/20 (With unsaturation outside the ring system) appears on 5 US grants and 5 published applications in this corpus.
Search patents in C07C- Granted patents
- 5
- Published applications
- 5
- Assignees
- 5
- Inventors
- 17
- Latest grant
- 17 May 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Medicinal use of serrulatane diterpenes17 May 2022US 11,331,299 B2Kynan Duke IP, LLC
- Medicinal use of serrulatane diterpenes9 Feb 2021US 10,912,742 B2The University of Sydney
- Preparation of 2,6- and 2,7-disubstituted anthraquinone derivates12 Mar 2019US 10,227,281 B2BASF SE
- Method of producing hydrogen peroxide and reaction promoters therefor12 Mar 2002US 6,355,815 B1Degussa AG
- Method of producing hydrogen peroxide and reaction promoters therefor28 Nov 2000US 6,153,169 ADegussa-Huls AG
- Medicinal use of serrulatane diterpenes21 Apr 2022US 2022/0117930 A2The University of Sydney
- Medicinal use of serrulatane diterpenes15 Jul 2021US 2021/0212982 A1The University of Sydney
- Medicinal use of serrulatane diterpenes19 Sep 2019US 2019/0282514 A1The University of Sydney
- Preparation of 2,6- and 2,7-disubstituted anthraquinone derivates2 Aug 2018US 2018/0215694 A1BASF SE
- Cd45 inhibitors6 Nov 2003US 2003/0207812 A1
Most cited
By later US patents
- Method of producing hydrogen peroxide and reaction promoters therefor9US 6,153,169 ADegussa-Huls AG · 2000
- Method of producing hydrogen peroxide and reaction promoters therefor4US 6,355,815 B1Degussa AG · 2002
- Preparation of 2,6- and 2,7-disubstituted anthraquinone derivates1US 10,227,281 B2BASF SE · 2019